首页> 外文期刊>World Journal of Gastroenterology >Perinuclear anti-neutrophil cytoplasmic antibodies (p-anca) in chronic ulcerative colitis: Experience in a Mexican institution.
【24h】

Perinuclear anti-neutrophil cytoplasmic antibodies (p-anca) in chronic ulcerative colitis: Experience in a Mexican institution.

机译:慢性溃疡性结肠炎中的核仁抗中性粒细胞胞浆抗体(p-anca):在墨西哥机构中的经验。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To assess the prevalence and clinical value of p-ANCA in a sample of Mexican ulcerative colitis (UC) patients. METHODS: In a prospective, IRB-approved protocol, p-ANCA was determined in 80 patients with UC (mean age, 32 +/- 12.9 years). The severity and extension of disease were determined by clinical methods, searching a statistical association with p-ANCA status. RESULTS: p-ANCA were detected in 41 (51%) patients. Severity of disease was the only clinical variable statistically associated with their presence (P<0.0001; OR = 9; CI 95% = 3.2-24.7). CONCLUSION: The prevalence of p-ANCA was similar to that reported in other countries. Their presence was associated to UC severity, but offered no more information than the obtained by clinical methods.
机译:目的:评估p-ANCA在墨西哥溃疡性结肠炎(UC)患者样本中的患病率和临床价值。方法:在一项经过IRB批准的前瞻性方案中,在80例UC患者(平均年龄32 +/- 12.9岁)中确定了p-ANCA。通过临床方法确定疾病的严重程度和范围,寻找与p-ANCA状态的统计关联。结果:在41(51%)患者中检测到p-ANCA。疾病的严重程度是唯一统计上与其存在相关的临床变量(P <0.0001; OR = 9; CI 95%= 3.2-24.7)。结论:p-ANCA的患病率与其他国家相似。它们的存在与UC的严重程度有关,但是所提供的信息不超过通过临床方法获得的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号